Yi, R., Lin, A., Cao, M., Xu, A., Luo, P., & Zhang, J. (2020). ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment. Front Genet.

Yi, Ruibin, Anqi Lin, Manming Cao, Abai Xu, Peng Luo, και Jian Zhang. "ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors By Acting On the Tumor Immune Microenvironment." Front Genet 2020.

Yi, Ruibin, et al. "ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors By Acting On the Tumor Immune Microenvironment." Front Genet 2020.